BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12530581)

  • 1. Dermatofibrosarcoma protuberans with EMa+ cells. Report of a case suggesting perineurial cell differentiation.
    Zamecnik M; Michal M; Baumruk L; Mukensnabl P
    Pathol Res Pract; 2002; 198(11):767-74; discussion 775. PubMed ID: 12530581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMA+ cells in dermatofibrosarcoma protuberans. A study of 11 tumors suggesting perineurial cell differentiation.
    Zámecník M; Michal M
    Cesk Patol; 2002 Apr; 38(2):55-62. PubMed ID: 12426982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoid differentiation and EMA expression in fibrosarcomatous dermatofibrosarcoma protuberans.
    Arican O; Bakaris S; Bulbuloglu E; Ezberci F
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Mar; 15(1):39-44. PubMed ID: 16850098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineurial cell differentiation in neurofibromas. Report of eight cases including a case with composite perineurioma-neurofibroma features.
    Zamecnik M; Michal M
    Pathol Res Pract; 2001; 197(8):537-44. PubMed ID: 11518046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans.
    McNiff JM; Subtil A; Cowper SE; Lazova R; Glusac EJ
    J Cutan Pathol; 2005 Jul; 32(6):413-8. PubMed ID: 15953374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls.
    Wang J; Yang W
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():65-9. PubMed ID: 18544057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features.
    Orlandi A; Bianchi L; Spagnoli LG
    J Cutan Pathol; 1998 Aug; 25(7):386-93. PubMed ID: 9765025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
    Kovarik CL; Hsu MY; Cockerell CJ
    J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report.
    Maeda T; Hirose T; Furuya K; Shirakawa K; Kobayashi K
    Mod Pathol; 1998 May; 11(5):491-5. PubMed ID: 9619604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
    Fanburg-Smith JC; Miettinen M
    Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrophic dermatofibrosarcoma protuberans with diffuse eosinophilic infiltrate.
    Hirashima N; Misago N; Shinogi T; Inoue T; Miura Y; Narisawa Y
    J Dermatol; 2006 Jul; 33(7):486-8. PubMed ID: 16848822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosarcomatous dermatofibrosarcoma protuberans with myofibroblastic differentiaion: a histologically distinctive variant [corrected].
    O'Connell JX; Trotter MJ
    Mod Pathol; 1996 Mar; 9(3):273-8. PubMed ID: 8685227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
    Labonte S; Hanna W; Bandarchi-Chamkhaleh B
    J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatofibroma and dermatofibrosarcoma protuberans: a comparative ultrastructural study.
    Dominguez-Malagon H; Valdez-Carrillo Mdel C; Cano-Valdez AM
    Ultrastruct Pathol; 2006; 30(4):283-91. PubMed ID: 16971353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis.
    Sabater-Marco V; Pérez-Vallés A; Berzal-Cantalejo F; Rodriguez-Serna M; Martinez-Diaz F; Martorell-Cebollada M
    Int J Dermatol; 2006 Jan; 45(1):59-62. PubMed ID: 16426380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell fibroblastoma: a report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans.
    Goldblum JR
    Arch Pathol Lab Med; 1996 Nov; 120(11):1052-5. PubMed ID: 12049108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
    Haycox CL; Odland PB; Olbricht SM; Piepkorn M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall.
    Abdaljaleel MY; North JP
    Am J Dermatopathol; 2017 Feb; 39(2):83-88. PubMed ID: 28134725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.